ÖÐÎÄÃû³Æ£º Íÿ¹PRMT5¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-PRMT5 rabbit polyclonal antibody
±ð Ãû£º JBP1, SKB1, IBP72, SKB1Hs, HRMT1L5
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£©
ËÞ Ö÷£º Rabbit
¿¹ Ô£º PRMT5
·´Ó¦ÖÖÊô£º Human, Mouse, Rat
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
Protein arginine methyltransferase 5 has been shown to interact with WD repeat-containing protein 77, CLNS1A, Janus kinase 2, SNRPD3 and SUPT5H.Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles. Methylates SUPT5H. Mono- and dimethylates arginine residues of myelin basic protein (MBP) in vitro. Plays a role in the assembly of snRNP core particles. May play a role in cytokine-activated transduction pathways. Negatively regulates cyclin E1 promoter activity and cellular proliferation. |
|
Applications: |
ELISA, WB, IHC |
|
Name of antibody: |
PRMT5 |
|
Immunogen: |
Synthetic peptide of human PRMT5 |
|
Full name: |
protein arginine methyltransferase 5 |
|
Synonyms£º |
JBP1, SKB1, IBP72, SKB1Hs, HRMT1L5 |
|
SwissProt: |
O14744 |
|
ELISA Recommended dilution: |
1000-2000 |
|
IHC positive control: |
Human breast cancer and Human tonsil |
|
IHC Recommend dilution: |
15-50 |
|
WB Predicted band size: |
71 kDa |
|
WB Positive control: |
K562, hela and 293T cells |
|
WB Recommended dilution: |
200-1000 |


¹ºÎï³µ
°ïÖú
021-54845833/15800441009
